Teladoc Health (NYSE:TDOC) Stock Price Down 9.3% – Time to Sell?

Teladoc Health, Inc. (NYSE:TDOC)’s share price traded down 9.3% during mid-day trading on Monday . The company traded as low as $7.89 and last traded at $7.8250. 2,793,173 shares changed hands during trading, a decline of 61% from the average session volume of 7,084,722 shares. The stock had previously closed at $8.63.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, October 8th. Zacks Research raised shares of Teladoc Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 10th. Citigroup raised their target price on shares of Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a report on Tuesday, October 21st. Mizuho initiated coverage on shares of Teladoc Health in a report on Friday, July 25th. They issued a “neutral” rating and a $10.00 target price on the stock. Finally, Evercore ISI dropped their price target on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $9.73.

Teladoc Health Stock Down 6.4%

The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of -6.31 and a beta of 1.90. The firm’s 50 day simple moving average is $8.23 and its 200-day simple moving average is $7.72.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.05. The company had revenue of $626.44 million for the quarter, compared to analyst estimates of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The business’s revenue was down 2.2% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently made changes to their positions in TDOC. Nuveen LLC purchased a new stake in shares of Teladoc Health in the 1st quarter worth about $11,789,000. Vanguard Group Inc. increased its stake in shares of Teladoc Health by 7.0% during the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock valued at $157,229,000 after acquiring an additional 1,289,183 shares during the last quarter. Bridgeway Capital Management LLC acquired a new stake in Teladoc Health during the 2nd quarter worth approximately $8,729,000. Trexquant Investment LP increased its position in Teladoc Health by 198.9% during the 1st quarter. Trexquant Investment LP now owns 907,859 shares of the health services provider’s stock worth $7,227,000 after purchasing an additional 604,116 shares in the last quarter. Finally, Empowered Funds LLC acquired a new stake in Teladoc Health during the 2nd quarter worth approximately $5,040,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.